Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation.
about
RANK-RANKL signalling in cancerJuvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANKThe RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.Pro-osteoclastic in vitro effect of Polyethylene-like nanoparticles: Involvement in the pathogenesis of implant aseptic loosening.
P2860
Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Novel RANK antagonists for the ...... s and experimental validation.
@en
Novel RANK antagonists for the ...... s and experimental validation.
@nl
type
label
Novel RANK antagonists for the ...... s and experimental validation.
@en
Novel RANK antagonists for the ...... s and experimental validation.
@nl
prefLabel
Novel RANK antagonists for the ...... s and experimental validation.
@en
Novel RANK antagonists for the ...... s and experimental validation.
@nl
P2093
P2860
P356
P1476
Novel RANK antagonists for the ...... s and experimental validation.
@en
P2093
Céline Charrier
Gildas Bertho
Kosei Ando
Marc Baud'huin
Marie-Françoise Heymann
Soizic Hervouet
Stéphane Téletchéa
Verena Stresing
P2860
P304
P356
10.1002/JBMR.2170
P577
2014-06-01T00:00:00Z